Dobutamine-Induced Myoclonus in a Patient With Advanced Heart Failure and Chronic Kidney Disease

Dobutamine is a positive inotropic agent often used in treatment of cardiogenic shock. Although there are well-documented adverse effects, dobutamine-induced myoclonus is a rarely reported phenomenon. Our case offers a direct and temporally related description of myoclonus, with onset observed withi...

Full description

Saved in:
Bibliographic Details
Published inJACC. Case reports Vol. 29; no. 6; p. 102255
Main Authors Lee, Alexander Y, Barforoshi, Shiva, Singh, Alvin, Shrestha, Ritesh, Ha, James, Kittleson, Michelle
Format Report
LanguageEnglish
Published 20.03.2024
Online AccessGet full text

Cover

More Information
Summary:Dobutamine is a positive inotropic agent often used in treatment of cardiogenic shock. Although there are well-documented adverse effects, dobutamine-induced myoclonus is a rarely reported phenomenon. Our case offers a direct and temporally related description of myoclonus, with onset observed within hours of dobutamine initiation and complete resolution within minutes of discontinuation.
Bibliography:ObjectType-Case Study-2
content type line 59
SourceType-Reports-1
ObjectType-Report-1
ISSN:2666-0849
DOI:10.1016/j.jaccas.2024.102255